[go: up one dir, main page]

KR950703960A - 혈소판 응집 억제제(platelet aggregation inhibitor) - Google Patents

혈소판 응집 억제제(platelet aggregation inhibitor)

Info

Publication number
KR950703960A
KR950703960A KR1019950701664A KR19950701664A KR950703960A KR 950703960 A KR950703960 A KR 950703960A KR 1019950701664 A KR1019950701664 A KR 1019950701664A KR 19950701664 A KR19950701664 A KR 19950701664A KR 950703960 A KR950703960 A KR 950703960A
Authority
KR
South Korea
Prior art keywords
platelet aggregation
aggregation inhibitor
inhibitor
platelet
aggregation
Prior art date
Application number
KR1019950701664A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950703960A publication Critical patent/KR950703960A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1019950701664A 1992-11-02 1995-04-28 혈소판 응집 억제제(platelet aggregation inhibitor) KR950703960A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31773992 1992-11-02
JP4352151A JP2806192B2 (ja) 1992-11-02 1992-12-10 血小板凝集抑制剤
PCT/JP1993/001527 WO1994009784A1 (en) 1992-11-02 1993-10-22 Platelet aggregation inhibitor

Publications (1)

Publication Number Publication Date
KR950703960A true KR950703960A (ko) 1995-11-17

Family

ID=26569128

Family Applications (2)

Application Number Title Priority Date Filing Date
KR95701664A KR0145196B1 (en) 1992-11-02 1995-04-28 Platelet aggregation inhibitor
KR1019950701664A KR950703960A (ko) 1992-11-02 1995-04-28 혈소판 응집 억제제(platelet aggregation inhibitor)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR95701664A KR0145196B1 (en) 1992-11-02 1995-04-28 Platelet aggregation inhibitor

Country Status (8)

Country Link
US (1) US5663172A (ko)
EP (1) EP0667158A4 (ko)
JP (1) JP2806192B2 (ko)
KR (2) KR0145196B1 (ko)
AU (1) AU674550B2 (ko)
CA (1) CA2148078C (ko)
NO (1) NO951650D0 (ko)
WO (1) WO1994009784A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2806192B2 (ja) * 1992-11-02 1998-09-30 日本曹達株式会社 血小板凝集抑制剤
WO1996015117A1 (fr) * 1994-11-11 1996-05-23 Nippon Soda Co., Ltd. Compose optiquement actif
DE19514568A1 (de) * 1995-04-20 1996-10-24 Merck Patent Gmbh Arylalkyl-pyridazinone
KR100811865B1 (ko) * 2006-12-08 2008-03-10 주식회사 레고켐 바이오사이언스 인자 Ⅶa 억제 활성을 갖는 피리미디논 또는 피리다지논유도체
CN110117257B (zh) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 一种含胍基的p2y12受体拮抗剂、制备方法及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU621087B2 (en) * 1988-02-13 1992-03-05 Nippon Soda Co., Ltd. Pyridazinone derivatives
JP2717687B2 (ja) * 1988-02-13 1998-02-18 日本曹達株式会社 ピリダジノン誘導体及びその製造方法
ES2131506T3 (es) * 1990-09-21 1999-08-01 Rohm & Haas Dihidropiridacinonas y piridacinonas como fungicidas.
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JPH05140116A (ja) * 1991-11-21 1993-06-08 Nippon Soda Co Ltd 光学活性な化合物
JP2806192B2 (ja) * 1992-11-02 1998-09-30 日本曹達株式会社 血小板凝集抑制剤

Also Published As

Publication number Publication date
AU674550B2 (en) 1997-01-02
EP0667158A4 (en) 1997-12-17
KR0145196B1 (en) 1998-07-15
CA2148078A1 (en) 1994-05-11
AU5286293A (en) 1994-05-24
US5663172A (en) 1997-09-02
JP2806192B2 (ja) 1998-09-30
NO951650L (no) 1995-04-28
JPH06192098A (ja) 1994-07-12
CA2148078C (en) 1998-06-09
NO951650D0 (no) 1995-04-28
WO1994009784A1 (en) 1994-05-11
EP0667158A1 (en) 1995-08-16

Similar Documents

Publication Publication Date Title
DE4394393T1 (de) Kühlkörper
NO931286D0 (no) Foeringsroer-pakker
EE03616B1 (et) Uued vereliistakute agregatsiooni pärssivad ained
FI933434A0 (fi) Fast fasanalys
NO934380D0 (no) Hurtigb}t
DE69308577D1 (de) Gefrierdose
ATE172738T1 (de) Substituierte 6-aza-androstenone
NO952289D0 (no) Substituerte benzazepinoner
FI941052L (fi) Kollageenin indusoiman verihiutaleaggregaation inhibiittori
KR950703960A (ko) 혈소판 응집 억제제(platelet aggregation inhibitor)
DE59309389D1 (de) Substituierte Thiophencarbonsäureamide
FI934244A0 (fi) Kylsapparat foer flamring
ATA141192A (de) Kältemaschine
DE59308065D1 (de) Verpackung
DE59310082D1 (de) Substituierte 2-arylpyrrole
KR930023640U (ko) 풀 냉각장치
KR940003938U (ko) 냉장고
ATA193592A (de) Verpackung
KR940017158U (ko) 기타
KR940000228U (ko) 재치대
SE9200936D0 (sv) Fast kondom
ATA90092A (de) Kaeltemaschine
KR940001590U (ko) 냉장고
KR940008682U (ko) 쿼드프랫 패키지
SE9200832L (sv) Förpackning

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 19950428

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19950428

Comment text: Request for Examination of Application

PG1501 Laying open of application
E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19980302

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19980428

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19980428

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20020110